Patents by Inventor Yves Rolland
Yves Rolland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9643825Abstract: A system allowing automatic detection of the end of winding of a cable on a winch comprises an optical detector which emits, in the direction of the cable, a light beam which illuminates a given zone through which the cable travels in the course of its winding. The detector is associated with a specific marking, strongly reflecting, positioned on a section of the cable close to its end, such that, when this section enters into the zone illuminated by the detector, it reflects the beam in the direction of the detector which detects this reflected beam and which then signals that the cable is almost at the end of winding. The detector, placed in a fixed position at a given distance from the cable, is also associated with a light waveguide interposed between the cable and the optical detector.Type: GrantFiled: August 14, 2012Date of Patent: May 9, 2017Assignee: THALESInventor: Yves Rolland
-
Publication number: 20140239165Abstract: A system allowing automatic detection of the end of winding of a cable on a winch comprises an optical detector which emits, in the direction of the cable, a light beam which illuminates a given zone through which the cable travels in the course of its winding. The detector is associated with a specific marking, strongly reflecting, positioned on a section of the cable close to its end, such that, when this section enters into the zone illuminated by the detector, it reflects the beam in the direction of the detector which detects this reflected beam and which then signals that the cable is almost at the end of winding. The detector, placed in a fixed position at a given distance from the cable, is also associated with a light waveguide interposed between the cable and the optical detector.Type: ApplicationFiled: August 14, 2012Publication date: August 28, 2014Applicant: THALESInventor: Yves Rolland
-
Patent number: 7999009Abstract: Strontium salts of the sulphonic acids of formula (I): A-B—SO3H??(I), wherein: A represents a group selected from OH, NH2, SO3H and CO2H, B represents an arylene group or an optionally substituted linear or branched C1-C12alkylene chain wherein one or more carbon atoms of the alkylene chain may be optionally replaced by an oxygen atom, by a nitrogen atom or by an SO2 group. Medicinal products containing the same which are useful in the treatment of osteoarthritis and osteoporosis.Type: GrantFiled: April 9, 2007Date of Patent: August 16, 2011Assignee: Les Laboratoires ServierInventors: Francois Lefoulon, Yves Rolland
-
Publication number: 20070244191Abstract: Strontium salts of the sulphonic acids of formula (I): A-B—SO3H , ??(I) wherein: A represents a group selected from OH, NH2, SO3H and CO2H, B represents an arylene group or an optionally substituted linear or branched C1-C12alkylene chain wherein one or more carbon atoms of the alkylene chain may be optionally replaced by an oxygen atom, by a nitrogen atom or by an SO2 group. Medicinal products containing the same which are useful in the treatment of osteoarthritis and osteoporosis.Type: ApplicationFiled: April 9, 2007Publication date: October 18, 2007Applicant: LES LABORATOIRES SERVIERInventors: Francois Lefoulon, Yves Rolland
-
Patent number: 5889003Abstract: A compound of general formula (I): ##STR1## in which: R.sub.1 represents alkyl,X represents oxygen, --CHR'-- or --CR'.dbd.,R' is chosen from hydrogen and alkyl,R.sub.2 represents optionally substituted alkyl as is defined in the description, cycloalkyl or polycycloalkyl as are defined in the description,R.sub.3 represents hydrogen or hydroxyl,Alk represents alkylene, andY is as defined in the description,and medicinal products containing the same are useful as PDE IV inhibitors.Type: GrantFiled: September 26, 1997Date of Patent: March 30, 1999Assignee: Adir Et CompagnieInventors: Alain Dhainaut, Guy Lewin, Emmanuel Canet, Michel Lonchampt, Yves Rolland
-
Patent number: 5849745Abstract: A compound of formula (I): ##STR1## In which: R.sub.1 represents linear or branched (C.sub.1 -C.sub.6) alkyl,X represents oxygen or sulfur,R.sub.2 represents optionally substituted alkyl, alkoxy, optionally substituted phenyl, optionally substituted cycloalkyl, 4-(2,3-dithiacyclopent-1-yl)butyl, pyridyl or optionally substituted amino or any one of the groups as defined in the description,R.sub.3 represents hydrogen or cycloalkyl, formyl, optionally substituted phenyl, pyridyl or optionally substituted alkyl,the isomers thereof, the addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal compounds containing them are useful for the treatment of chronic or cellular ischemia.Type: GrantFiled: December 15, 1997Date of Patent: December 15, 1998Assignee: ADIR et CompagnieInventors: Michel Wierzbicki, Marie-Fran.cedilla.oise Boussard, Serge Labidalle, Daniel Guyot, Yves Rolland, Jean-Paul Tillement, Bernard Testa, Aime Crevat
-
Patent number: 5654323Abstract: A compound of formula (I): ##STR1## in which X, n, B and Y are as defined in the description. useful as cytokine inhibitors.Type: GrantFiled: June 1, 1995Date of Patent: August 5, 1997Assignee: Adir et CompagnieInventors: Jean-Daniel Brion, Anne-Marie Chollet, Luc Demuynck, Lucy De Montarby, Yves Rolland, Jacqueline Bonnet, Pietro Ghezzi, Armel Fradin
-
Patent number: 5629339Abstract: Disclosed herein are new diosmetin compounds of formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the description.The said compounds are useful in the treatment of chronic venous insufficiency.Type: GrantFiled: October 24, 1995Date of Patent: May 13, 1997Assignee: Adir et CompagnieInventors: Michel Wierzbicki, Marie-Fran.cedilla.oise Boussard, Tony Verbeuren, Marie-Odile Vallez, Emmanuel Canet, Yves Rolland
-
Patent number: 5599975Abstract: A compound selected from those of formula (I): ##STR1## wherein A, X, Y, Z, R, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined in the description.This compound or its physiologically tolerable salts may be used therapeutically as platelet anti-aggregation agent.Type: GrantFiled: October 27, 1994Date of Patent: February 4, 1997Assignee: Adir Et CompagnieInventors: Ren e Gree, Ali M. Hachem, Danielle Gree, Yves Le Floc'h, Yves Rolland, Serge Simonet, Tony Verbeuren
-
Patent number: 5597819Abstract: New benzothiazine derivatives corresponding to the general formula I: ##STR1## in which: X represents halogen,n represents 0, 1, or 2,B represents the following formula: ##STR2## in which: R.sub.1 & R.sub.2 together with the carbons to which they are attached form a 6-carbon-atom aromatic ring which is optionally substituted by a group X' representing halogen, andY represents the radical --(SO.sub.2).sub.x --Alk--Z, x, Alk, and Z are as defined in the specification;as well as their possible stereoisomers, epimers, N-oxides and pharmaceutically-acceptable acid or base addition salts; and medicinal products containing the same, useful in the treatment of inflammatory disorders requiring an inhibitor of cytokines.Type: GrantFiled: February 13, 1995Date of Patent: January 28, 1997Assignee: Adir Et CompagnieInventors: Jean-Daniel Brion, Anne-Marie Chollet, Luc Demuynck, Lucy De Montarby, Yves Rolland, Jacqueline Bonnet, Pietro Ghezzi, Armel Fradin
-
Patent number: 5567707Abstract: Compounds of formula (I): ##STR1## wherein R.sub.3, R.sub.4, R.sub.5, R.sub.6, X and Y are defined in the description.Those compounds are used therapeutically in the treatment of cancerous tumours.Type: GrantFiled: February 16, 1995Date of Patent: October 22, 1996Assignee: Adir et CompagnieInventors: Michel Koch, Fran.cedilla.ois Tillequin, Alexios-Leandros Skaltsounis, Yves Rolland, Alain Pierre, Ghanem Atassi
-
Patent number: 5550143Abstract: A compound of formula (I): ##STR1## in which X, n, B and Y are as defined in the description. useful as cytokine inhibitors.Type: GrantFiled: April 12, 1994Date of Patent: August 27, 1996Assignee: Adir et CompagnieInventors: Jean-Daniel Brion, Anne-Marie Chollet, Luc Demuynck, Lucy De Montarby, Yves Rolland, Jacqueline Bonnet, Pietro Ghezzi, Armel Fradin
-
Patent number: 5520135Abstract: An apparatus installed on board any maritime support for hoisting and handling loads at sea, the apparatus having at least one winch on which a cable is wound that enables the load to be raised, a gantry carrying suspension systems for the cable, and enabling the cable together with the load to be moved overboard relative to an edge of the maritime support in order to launch the load, and any fixed guidance and deflection systems close to the edge of the support and capable of receiving the cable after the launching and while the load is in use.Type: GrantFiled: May 20, 1994Date of Patent: May 28, 1996Assignee: France TelecomInventors: Yves Rolland, Alain Nizou
-
Patent number: 5492913Abstract: The compounds are N-(unsubstituted or substituted) N'-benzylpiperazine compounds and pharmaceutically tolerable salts thereof, useful for treating neuronal disorders resulting from the dysfunctioning of oxidative metabolism.A compound disclosed is: N-ethyl N'-(2-hydroxy-3,4- dimethoxybenzyl)-piperazine and its dihydrochloride.Type: GrantFiled: March 23, 1994Date of Patent: February 20, 1996Assignee: Adir et CompagnieInventors: Michel Wierzbicki, Jean Lepagnol, Jean-Paul Tillement, Bernard Testa, Yves Rolland
-
Patent number: 5457103Abstract: Compounds of the general formula (I): ##STR1## in which R represents: a hydrogen atom, ora radical --OR'in which R' is as defined in the description.Type: GrantFiled: August 18, 1993Date of Patent: October 10, 1995Assignee: Adir et CompagnieInventors: Yves Rolland, Guy Lewin, Jean-Paul Vilaine, Albert Lenaers, Catherine Thollon
-
Patent number: 4970301Abstract: Compound of general formula I: ##STR1## in which: A is a single or double bond,R.sub.1 and R.sub.3, which may be identical or different, are each a hydrogen atom, an alkoxycarbonylmethylene radical of formula --CH.sub.2 CO.sub.2 R.sub.4 (in which R.sub.4 denotes an alkyl radical having 1 to 5 carbon atoms) or a radical of formula W: ##STR2## (in which n is equal to 0 or 1 and R.sub.5, R.sub.6 and R.sub.7, which may be identical or different, are each a hydrogen or halogen atom, a hydroxyl radical, a trifluoromethyl radical, a lower alkyl radical containing 1 to 5 carbon atoms or an alkoxy radical containing 1 to 5 carbon atoms),R.sub.2 is a hydrogen atom, an alkoxycarbonylmethylene radical of formula --CH.sub.2 CO.sub.2 R.sub.4, a radical of formula W, or a .beta.-glucose or rutinose molecule linked to the oxygen to which it is attached with a glycoside bond,on condition, however, that at least either R.sub.1 or R.sub.2 or R.sub.Type: GrantFiled: November 29, 1988Date of Patent: November 13, 1990Assignee: Adir et CieInventors: Yves Rolland, Jacques DuHault